GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE1862.30-26.9 (-1.42 %)

PREV CLOSE ( ) 1889.20

OPEN PRICE ( ) 1856.90

BID PRICE (QTY) 1859.75 (4)

OFFER PRICE (QTY) 1865.65 (3)

VOLUME 895

TODAY'S LOW / HIGH ( )1846.25 1868.60

52 WK LOW / HIGH ( )1228 2649.95

NSE1878.15-10 (-0.53 %)

PREV CLOSE( ) 1888.15

OPEN PRICE ( ) 1878.15

BID PRICE (QTY) 1878.15 (66)

OFFER PRICE (QTY) 1879.90 (50)

VOLUME 204

TODAY'S LOW / HIGH( ) 1878.15 1878.15

52 WK LOW / HIGH ( )1227 2524

More From Company Profile

Select year

Particulars	Mar2023	Mar2022	Mar2021	Mar2020	Mar2019
Operational & Financial Ratios
Earnings Per Share (Rs)	35.70	22.23	16.92	6.50	25.11
CEPS(Rs)	39.58	26.25	21.56	11.38	27.98
DPS(Rs)	32.00	90.00	30.00	40.00	20.00
Book NAV/Share(Rs)	103.58	158.06	88.37	108.62	126.47
Tax Rate(%)	27.35	51.31	36.75	65.88	35.91
Margin Ratios
Core EBITDA Margin(%)	22.63	21.39	19.16	19.58	19.39
EBIT Margin(%)	23.61	21.94	14.64	9.78	21.23
Pre Tax Margin(%)	23.56	21.89	14.53	9.59	21.21
PAT Margin (%)	17.12	10.66	9.19	3.27	13.60
Cash Profit Margin (%)	18.98	12.59	11.71	5.73	15.15
Performance Ratios
ROA(%)	15.70	10.04	9.53	2.04	5.53
ROE(%)	27.29	18.04	17.18	5.53	20.15
ROCE(%)	37.66	37.15	27.37	16.51	31.45
Asset Turnover(x)	0.92	0.94	1.04	0.62	0.41
Sales/Fixed Asset(x)	5.69	5.93	3.04	3.34	6.48
Working Capital/Sales(x)	3.07	1.77	4.64	4.46	5.83
Efficiency Ratios
Fixed Capital/Sales(x)	0.18	0.17	0.33	0.30	0.15
Receivable days	20.54	21.73	18.45	11.96	15.60
Inventory Days	49.10	53.51	58.87	52.62	57.56
Payable days	142.20	141.33	117.18	105.65	122.09
Valuation Parameters
PER(x)	37.10	74.81	85.11	191.68	51.77
PCE(x)	33.46	63.34	66.80	109.45	46.46
Price/Book(x)	12.78	10.52	16.30	11.46	10.28
Yield(%)	2.42	5.41	2.08	3.21	1.54
EV/Net Sales(x)	6.62	7.99	7.96	6.21	6.67
EV/Core EBITDA(x)	23.62	30.88	32.83	27.21	29.47
EV/EBIT(x)	25.51	33.13	50.89	60.91	31.41
EV/CE(x)	6.66	5.70	7.76	6.63	2.68
M Cap / Sales	6.97	8.76	8.36	6.54	7.04
Growth Ratio
Net Sales Growth(%)	-0.04	10.17	-9.43	3.07	8.94
Core EBITDA Growth(%)	8.28	17.53	-3.81	3.96	25.98
EBIT Growth(%)	7.58	69.77	38.90	-50.50	22.61
PAT Growth(%)	60.58	31.35	160.50	-74.13	20.85
EPS Growth(%)	60.58	31.35	160.50	-74.13	-39.58
Financial Stability Ratios
Total Debt/Equity(x)	0.00	0.00	0.00	0.00	0.00
Current Ratio(x)	1.87	2.19	1.51	1.75	1.19
Quick Ratio(x)	1.54	1.89	1.11	1.27	1.02
Interest Cover(x)	460.68	389.70	129.34	51.90	1198.38
Total Debt/Mcap(x)	0.00	0.00

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Portfolio Management Service (PMS) NBSPL - PMS Disclosure Nirmal Bang PMS - Investor Charter SCORES complaints – March 2024

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

NPS NPS Forms and Guidelines NPS-AML Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Risk Disclosure Grievances NPS Grievance Policy SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Client Bank Account list Smartodr Login Investor Grievance Flow Registered AP’s Surrendered List of AP’s KYC Activation Process

Connect with Us

ATTENTION INVESTORS Depository IPO KYC Investor Guide

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL PMS Disclosure Document

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment INZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Financial Ratios

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

Physical Settlement Policy of Derivative

Download Client Registration Documents

RISK DISCLOSURES ON DERIVATIVES